Quadrivalent flu vaccine to replace trivalent

A new quadrivalent vaccine will replace Fluvax, Sequiris’ trivalent vaccine for the 2017 flu season.“It is generally accepted that QIV is becoming the preferred seasonal vaccine, as was the case with bivalents when the industry moved to trivalents,” Sequirus’ Dr Jane Leong, Head of Medical Affairs, Asia Pacific, told the AJP today.“The traditional seasonal influenza

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 'Beady greedy eyes of pharmacy owners' - What you said
Next Weekly Dose: sofosbuvir – what's the price of a hepatitis C cure?